Siemens Healthineers upgrades AI-powered Acuson Sequoia ultrasound
Siemens Healthineers has unveiled a significant upgrade to its Acuson Sequoia ultrasound platform, introducing AI Abdomen technology that promises to revolutionise sonographic workflows. The system’s AI-driven features aim to reduce operator strain while enhancing diagnostic precision through automated anatomical recognition and standardised measurements.
Advanced ergonomics meets artificial intelligence
The landmark AI Abdomen technology addresses a critical challenge in ultrasound diagnostics, demonstrating up to 89% reduction in sonographer hand motion compared to manual examinations. This innovation particularly benefits the 90% of ultrasound practitioners who report scanning-related pain, targeting specific ergonomic challenges including transducer pressure application and physical positioning.
The system’s sophisticated algorithm automatically identifies and labels 17 distinct anatomical views while calculating 12 essential measurements, establishing a new benchmark for examination consistency. This standardisation effectively minimises inter-operator variability, potentially enhancing diagnostic reliability across different clinical settings.
Enhanced breast and musculoskeletal capabilities
The Acuson Sequoia 3.5 introduces the HLX transducer, representing the company’s highest-frequency linear imaging capability. This advancement combines with proprietary 2D Shear Wave technology to optimise breast lesion identification and characterisation. The transducer’s ergonomic design specifically addresses challenges in musculoskeletal imaging, facilitating detailed visualisation of both large mobile tissues and minute superficial structures.
Liver assessment innovations
Notable additions include proprietary quantification tools – Ultrasound Derived Fat Fraction (UDFF) and Auto Point Shear Wave Elastography (Auto pSWE). These technologies enable simultaneous assessment of hepatic steatosis and liver tissue stiffness in a single acquisition, advancing non-invasive liver disease evaluation capabilities.
The Acuson Sequoia 3.5 has received FDA clearance and CE marking. This release represents a significant step forward in the integration of artificial intelligence with practical clinical ultrasonography, setting new standards for diagnostic workflow efficiency and measurement consistency.
- For more information about the Acuson Sequoia 3.5, visit:
https://www.siemens-healthineers.com/ultrasound/new-era-ultrasound/acuson-sequoia
